Ceribell CBLL 深 沪
等待开盘 09-18 09:30:00 美东时间
11.99
+0.320
+2.74%
华盛通- 最 高12.29
- 今 开11.77
- 成交量 13.25万股
- 最 低 11.745
- 昨 收 11.67
- 总市值 4.40亿
- 52周最高 32.7489
- 市盈率 静 --
- 换手率 0.36%
- 52周最低 10.01
- 委 比 -57.43%
- 总股本 3666.40万
- 历史最高 32.7489
- 量 比 0.64
- 振 幅 4.67%
- 历史最低 10.01
- 每 手 1
- 风险率 3.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CeriBell shares are trading lower. The company reported Q2 financial results.
CeriBell shares are trading lower. The company reported Q2 financial results.
08-06 23:46
CeriBell Raises FY2025 Sales Guidance from $83.000M-$87.000M to $85.000M-$88.000M vs $85.960M Est
CeriBell (NASDAQ:CBLL) raises FY2025 sales outlook from $83.000 million-$87.000 million to $85.000 million-$88.000 million vs $85.960 million estimate.
08-06 04:14
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
Ceribell, Inc. (Nasdaq: CBLL) announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025, at 11:00 a.m. PST / 2:00 p.m. EST. A live and archived webcast will be available on the company's Investor Relations website. Ceribell, a medical technology company, focuses on advancing neurological patient care through its FDA-cleared Ceribell System, which aids in rapid diagn...
07-29 20:05
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
Ceribell, Inc. announced the release of its second-quarter 2025 financial results on August 5, 2025, after market close. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET same day to discuss results. A live and archived webcast is available on the company's investor relations page. Ceribell focuses on transforming neurological patient care and markets the FDA-cleared Ceribell System, used in U.S. ICUs and ERs. Headquartered in...
07-22 20:05
Ceribell sues Natus Medical for patent infringement
CeriBell (NASDAQ:CBLL) said on Monday that it has taken legal action against Natus Medical and its units, claiming that they have infringed on its patents and engaged in unfair competition. Ceribell h...
07-08 05:06
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
Ceribell, Inc. filed patent infringement lawsuits against Natus Medical Incorporated and its subsidiaries, alleging violations related to its EEG headband and electrode design technology. Ceribell requested the U.S. International Trade Commission (USITC) to investigate and issue an exclusion order to block Natus' infringing products from entering the U.S. Additionally, Ceribell filed a complaint with the U.S. District Court in Delaware. The compa...
07-07 20:42
Ceribell Extends Exclusive License with Stanford University
An announcement from Ceribell, Inc. ( ($CBLL) ) is now available. Ceribell, Inc...
06-21 01:18
AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 20, 2025 /PRNewswire/ -- Equity Insider News Commentary – Amid the wave of new AI-powered innov...
06-20 21:11
CeriBell Raises FY2025 Sales Guidance from $81.00M-$85.00M to $83.00M-$87.00M vs $83.72M Est
CeriBell (NASDAQ:CBLL) raises FY2025 sales outlook from $81.00 million-$85.00 million to $83.00 million-$87.00 million vs $83.72 million estimate.
05-09 06:54
